Universität Göttingen   >   FIT für die Wissenschaft

Schwerpunktprogramm 1230: "Mechanismus des Zelleintritts und der Persistenz von Genvektoren"
The Senate of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has decided to establish "Mechanisms of gene vector entry and persistence" as a new Priority Programme.
Emerging gene-based therapies have shown surprising efficiency as well as severe side effects. The Research Priority Programme "Mechanisms of gene vector entry and persistence" creates a multidisciplinary forum to address basic mechanisms of gene delivery into somatic cells, with a focus on hematopoietic and lymphatic systems. Projects investigating
-cell entry,
-episomal maintenance and
-chromosomal insertion of transgenes
are encouraged.
Proposals must be submitted to the DFG (in English) by Monday 5 September 2005 with the keyword "gene vector entry". It is anticipated that funding of individual projects will be able to commence in January 2006. Funding proposals can be made for a three year period.
For further information on the programme, contact the programme's scientific coordinator Prof. Christopher Baum, Hannover Medical School, Department IV: Children's Hospital - Pediatric Department of Hematology and Oncology, Carl-Neuberg-Strasse 1, D-30625 Hannover, GERMANY, Tel. +49(0)511 / 532 6067 e-mail: baum.christopher.mail.mh-hannover.de
For information on submitting proposals, contact Office LA8, Dr. Tobias Grimm, Kennedyallee 40, 53175 Bonn, Tel.: +49(0)228/885 2325, e-mail: tobias.grimm.mail.dfg.de